ISDSlogosmall.jpg

AUGUST 24-27

ISDS
 2022

15th INTERNATIONAL SKELETAL DYSPLASIA SOCIETY MEETING

pngwing.com (2).png

SANTIAGO DE CHILE

WHEN

AUGUST 24-27, 2022

ABOUT ISDS

The International Skeletal Dysplasia Society, ISDS is a non-profit organization, founded almost 30 years ago. The principal aim of the Society is to promote scientific progress in the field of skeletal dysplasias and dysostoses and related topics (which are genetic bone conditions).

To this aim, the society organizes meetings on a two-year basis.  The meetings are conducted in a friendly and familial way to promote networking and exchange of expertise. The scientific program of the meetings includes advances in the clinical, radiological, genetic, biochemical, and molecular characterization of skeletal dysplasia, as well as advances in management of individuals affected by skeletal dysplasia and dysostoses.

Since the beginning the meetings have been held in sites on different continents, being the last one in Oslo, Norway 2019.

ABOUT THE EVENT

We are pleased to announce that the "15th International Skeletal Dysplasia Society Meeting",
will be held in Santiago, Chile, on August 24 - 27, 2022,
and for the first time in Latin America


MEETING VENUE & LOCATION
Best Western Premier Marina Las Condes Hotel
Av. Alonso de Córdova Nº 5727
Santiago, 7560927
Chile

Hotel website
*Reduces rates are available for meeting attendees - "Limited vacancies"


We look forward to seeing you in Santiago!

 **INFORMATION ABOUT COVID-19**

The vaccination rate in Chile for persons over 18 years of age is over 94,09 % (updated as of July 29th, 2022).

Make sure you are fully vaccinated before traveling to Chile.


 


Health information:
According to the Protected Borders Plan, Chile is currently in Alert Phase 1, which does

not include travel restrictions. However, there are some measures to be considered.:
 

Fill in the “Travel Affidavit” form online up to 48 hours before boarding,

providing contact information and health and travel records.

This form will display a QR code as a means of verification. It is available at www.c19.cl.
 

Have health insurance with a minimum Covid-19 coverage of USD 30,000

(mandatory for non-residents). Medical insurance will not be required for

Spanish citizens, as long as they carry their Temporary Displacement (E/CHL-11)

and Residence (E/CHL-9) forms.

 

Diagnostic tests will be carried out randomly at the entry point to Chile.

Confirmed cases shall be isolated according to the general health regulations

(declared domicile in the C19 or Sanitary Residence).

Although it is not mandatory, we always advice you to undergo a diagnostic test before traveling.

Vaccine approval is voluntary. We recommend processing it, since it gives access to the Mobility Pass,

which allows entry to restaurants, theaters, buses, among others. Get it here.

 

Vaccine validation process

 

**International help desk +56 2 2871 7800 of the Ministry of Health.**

 


More official information: 

https://www.gob.cl/coronavirus/

https://www.chile.travel/en/traveltochileplan/

https://saludresponde.minsal.cl/validaciondevacunas/

SCHEDULE

Wednesday,

August 24th

Thursday,

August 25th

Registration

Welcome reception

Welcome address

Scientific sessions

David Rimoin Lecture

Optional social program

Friday,

August 26th

Saturday,

August 27th

Scientific sessions

ISDS general assembly

(ISDS members only)

Conference dinner

Patients-Families-Experts & coffee

Scientific sessions

Awards and closing remarks

MEETING TOPICS

 SCIENTIFIC PROGRAM

  • Fundamental research advances: pathogenic mechanisms, animal models.

  • Progress in delineation of skeletal dysplasias: nosology, genotype-phenotype correlation, expansion of phenotypes and «new» genes and conditions.

  • Prenatal skeletal dysplasias and lethal skeletal dysplasias - updating, new genes and new phenotypes.

  • Skeletal dysplasias in general focus in diagnosis: clinical, molecular and radiological.

  • Clinical records, clinical series, follow-up, and natural history.

  • Multidisciplinary management throughout the lifespan in skeletal dysplasias.

  • Impact on quality of life, pain, and functionality of skeletal dysplasias.

  • Current and future pharmacological approaches in genetic diseases of bone.

  • Ethical aspects and access opportunities.

  • Skeletal Dysplasias in Latin America.